Greg Meyers serves as Executive Vice President and Chief Digital and Technology Officer at Bristol Myers Squibb (BMS), a role he assumed in 2021. With over 25 years of experience in technology leadership within the pharmaceutical and healthcare sectors, Meyers previously held the position of Chief Digital and Technology Officer at Pfizer, where he spearheaded the company's digital transformation amid the COVID-19 pandemic. His earlier career included senior roles at Johnson & Johnson, Deloitte Consulting, and IBM, where he honed expertise in enterprise architecture, data analytics, and digital strategy, driving innovations that bridged technology with business outcomes. Throughout his tenure, Meyers has earned recognition for pioneering AI-driven solutions and cloud migrations that enhanced operational efficiency and accelerated drug development. At Pfizer, he led the digital infrastructure supporting the rapid rollout of the COVID-19 vaccine, integrating advanced analytics and automation to manage global supply chains and clinical trials. His achievements also include multiple industry awards, such as being named a "Top 25 Healthcare CTO" by CIO Review, underscoring his impact on leveraging emerging technologies like machine learning and cybersecurity to foster resilient health systems. At BMS, Meyers oversees the company's global digital and technology organization, encompassing IT operations, data science, cybersecurity, and digital product development. He is championing a patient-centric digital ecosystem, integrating AI and real-world data to streamline R&D pipelines and improve access to therapies. Under his leadership, BMS has advanced initiatives like the Digital Health Hub and partnerships with tech giants to harness generative AI, positioning the company at the forefront of biopharma innovation.